510(k) K254059

Access anti-HBc IgM by Beckman Coulter, Inc. — Product Code SEI

K254059 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "Access anti-HBc IgM". The FDA issued a decision of Substantially Equivalent on Mar 13, 2026. The device falls under product code SEI (Qualitative And Quantitative Hepatitis B Virus Antibody Assays), a Class II device regulated under 21 CFR 866.3173. Beckman Coulter, Inc. has 280 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 13, 2026
Date Received
Dec 17, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Qualitative And Quantitative Hepatitis B Virus Antibody Assays
Device Class
Class II
Regulation Number
866.3173
Review Panel
MI
Submission Type
510(k)

In vitro diagnostic devices intended for use in the detection of antibodies to HBV. These devices are intended to aid in the diagnosis of HBV infection in persons with signs and symptoms of hepatitis and in persons at risk for HBV infection. Anti-HBs assay results may be used as an aid in the determination of susceptibility to HBV infection in individuals prior to or following HBV vaccination or when vaccination status is unknown.

Need the full FDA record for Beckman Coulter, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K254059. Report a data issue: hello@regdatalab.com.